Angel White

PhD 2026

PhD Thesis: 

Protein kinase CK2alpha prime: A unifying regulator and therapeutic candidate in PolyQ expansion disorders and tauopathies.

Current Position 

Recent Graduate

Undergraduate Institution and Major:

Ohio State University, B.S. in Neuroscience, 2020

Graduate Publications:

  • White A, Gavrilyuk P, Gu P, Moya RF, Thurston R, Fickak A, Rozema NB, Keshavaram P, Vermilyea S, Schlichte R, Meints J, Zhang Y, Araque A, Lee M, Gomez-Pastor R. Protein . CK2α' as a dual modulator of immune signaling and synaptic dysfunction in Tauopathy. bioRxiv [Preprint]. 2025 Nov 25:2025.06.24.661391.
  • Mudaliar D, Mansky RH, White A, Baudhuin G, Hawkinson J, Wong H, Walters MA, Gomez-Pastor R. Discovery of a CK2α'-biased ATP-competitive inhibitor from a high-throughput screen of an allosteric-inhibitor-like compound library. ACS Chem Neurosci. 2024;15(15):2703-2718.
  • White A, McGlone A, Gomez-Pastor R. Protein kinase CK2 and its potential role as a therapeutic target in Huntington's Disease. Biomedicines. 2022;10(8):1979.
  • Yu D, Zarate N, White A, Coates D, Tsai W, Nanclares C, Cuccu F, Yue JS, Brown TG, Mansky RH, Jiang K, Kim H, Nichols-Meade T, Larson SN, Gundry K, Zhang Y, Tomas-Zapico C, Lucas JJ, Benneyworth M, Öz G, Cvetanovic M, Araque A, Gomez-Pastor R. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease. Acta Neuropathol Commun. 2022;10(1):83.

Graduate Advisor

Rocio Gomez-Pastor, Ph.D., Department of Neuroscience

White